Sechenov School
Home › Pharmacology › Rational Antibiotic Combination

Rational Antibiotic Combination

Imipenemum

For medical students2 min readUpdated 2026-10-10

The rational combination of antibacterial agents aims to enhance therapeutic effects through synergism while preventing dangerous combinations that lead to antagonism or toxicity. A prime example of specialized drug protection is imipenem, which requires the mandatory addition of an enzyme inhibitor.

Imipenem protectionDegraded in the kidneys by the enzyme dehydropeptidase I
InhibitorCilastatin protects imipenem from inactivation
SynergismAminoglycosides + penicillins produce a bactericidal effect
ToxicityAminoglycosides and polymyxins exhibit additive nephrotoxicity

Clinical Application of Carbapenems: Imipenem as an Example

Certain carbapenem antibiotics are vulnerable to host enzymes. Specifically, imipenem is rapidly degraded in the renal tubules by a specific enzyme: dehydropeptidase I.

To prevent this inactivation and guarantee a pronounced therapeutic effect, the drug is administered in a strict fixed combination with a specific inhibitor of this enzyme, cilastatin. Additionally, this drug group is poorly absorbed from the gastrointestinal tract, so all carbapenems are administered exclusively via parenteral routes—intravenously or intramuscularly.

Rational Combinations: Principles of Synergism

The primary goal of rational antimicrobial combination is to achieve mutual enhancement of activity without compromising patient safety.

Irrational Combinations: Antagonism and Toxicity

Certain antibiotic combinations are strictly contraindicated due to a high risk of pharmacodynamic conflict or additive adverse effects:

  1. Aminoglycosides + Polymyxins. A dangerous summation of toxic effects occurs. Both groups exhibit marked nephrotoxicity and neurotoxicity, increasing the risk of neuromuscular blockade.
  2. Tetracyclines + Penicillins. Pharmacodynamic antagonism occurs. Bactericidal penicillins are effective only against actively dividing cells, whereas bacteriostatic tetracyclines inhibit this process. As a result, the bacteriostatic agent sharply reduces the efficacy of the bactericidal drug.
  3. Macrolides + Lincosamides. Competitive antagonism develops because both groups target the exact same structure—the 50S subunit of the bacterial ribosome. The drugs compete for binding sites, weakening each other's effects and promoting cross-resistance.

Mnemonic

Imipenem without cilastatin 'burns up' in the kidneys, while tetracycline and penicillin argue: one stops cell division, while the other requires cellular activity.

Frequently asked questions

Which other antibiotics, besides tetracyclines, exhibit antagonism with penicillins?

In addition to tetracyclines, chloramphenicol group drugs exhibit antagonism with penicillins.

  • Chloramphenicol is a bacteriostatic agent.

Through pharmacodynamic interaction, it weakens the therapeutic effect of bactericidal antibiotics (including penicillins and aminoglycosides). This occurs because bactericidal agents act on actively dividing cells, whereas chloramphenicol suppresses their growth and reproduction.

Which other drugs belong to the carbapenem group alongside imipenem?

In addition to imipenem, the carbapenem group includes meropenem and ertapenem.

  • Meropenem is administered intravenously, lacks seizure-inducing activity, but is not used for bone and joint infections.
  • Ertapenem has a long half-life allowing once-daily dosing, but is less active than other carbapenems against non-fermenting Gram-negative bacteria (P. aeruginosa, Acinetobacter).

Both drugs can be used for community-acquired pneumonia with a risk of Enterobacteriaceae infection.

What other enzyme inhibitors are used to protect beta-lactam antibiotics?

To protect beta-lactam antibiotics from degradation, dehydropeptidase I inhibitors and beta-lactamase inhibitors are used.

  • Cilastatin is a specific dehydropeptidase I inhibitor that prevents the inactivation of imipenem in the renal tubules.
  • Clavulanic acid is a beta-lactamase inhibitor combined with amoxicillin and ticarcillin.
  • Sulbactam is a beta-lactamase inhibitor used with ampicillin or cefoperazone.
  • Tazobactam is a beta-lactamase inhibitor used in combination with piperacillin.

Beta-lactamase inhibitors contain a beta-lactam ring, bind to bacterial enzymes, and irreversibly inactivate them.

In which severe infections, other than endocarditis, is the combination of penicillins and aminoglycosides indicated?

In addition to infective endocarditis, combined therapy of gentamicin with antipseudomonal penicillins is indicated for Klebsiella infections. Gentamicin is also used systemically for severe Gram-negative infections, including sepsis, pneumonia, complicated urogenital, and intra-abdominal infections. The combination provides bactericidal synergism: penicillins disrupt cell wall synthesis, facilitating aminoglycoside entry into the bacterial cell.

Why is imipenem always prescribed in combination with cilastatin?

Imipenem is rapidly degraded in the renal tubules by the specific enzyme dehydropeptidase I. Cilastatin acts as an inhibitor of this enzyme, protecting the antibiotic from premature inactivation.

Why is the combination of penicillins and tetracyclines considered irrational?

This is a form of pharmacodynamic antagonism. Penicillins exert a bactericidal effect on actively dividing microorganisms, whereas tetracyclines (bacteriostatic agents) inhibit cell division, causing the efficacy of penicillins to drop sharply.

What is the mechanism of synergism between aminoglycosides and penicillins?

Beta-lactams (penicillins) disrupt the bacterial cell wall, which facilitates the penetration of aminoglycosides into the microbial cell toward their intracellular target: the ribosomes.

Go deeper

More topics in Pharmacology

RifampicinChlorpromazineErgometrine MaleateEthambutolSecond-Line Antitubercular DrugsBetaine PepsinAlmagate + Magnesium OxideBisacodylApomorphineBismuth Tripotassium DicitrateDiluted Hydrochloric AcidLoperamidePharmacology →